Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
tert-butylhydroquinone (TBHQ) is a synthetic aromatic organic compound, a type of phenol, and a derivative of hydroquinone. It is primarily utilized as an antioxidant preservative in the food, cosmetic, and pharmaceutical industries to prevent oxidation, inhibit lipid peroxidation, and extend the shelf life of various products. It functions by scavenging free radicals and is particularly effective in preventing rancidity in oils and fats. Beyond its preservative role, TBHQ has demonstrated biological activities, including enhancing Nrf2-mediated transcription by promoting the dissociation of Nrf2-Keap1, leading to Nrf2 stabilization and increased cellular antioxidant capabilities. Its oxidation product, tert-butylbenzoquinone (TBBQ), exhibits antibacterial activity by disrupting bacterial membrane integrity. Research also indicates its ability to stimulate AP-1 activation and matrix metalloproteinase-3 (MMP-3) expression, which has shown an aqueous outflow–enhancing effect in human donor eyes, suggesting potential therapeutic applications in conditions like glaucoma. Additionally, it has been investigated for its effects on estrogen receptor alpha (ERα) and tumor suppressor gene p53 in breast cancer cells, and for attenuating nephrotoxicity, hepatotoxicity, and neurotoxicity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on tert-butylhydroquinone.